Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis

Trial Profile

Non-Inferiority Clinical Trial On The Efficacy And Safety Of Chondroitin Sulfate And Glucosamine Hydrochloride In Combination Versus Celecoxib In Patients With Knee Osteoarthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Glucosamine/chondroitin sulfate (Primary) ; Celecoxib
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms MOVES
  • Sponsors Bioiberica
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Sep 2015 Status changed from active, no longer recruiting to completed, according to results published in the Annals of the Rheumatic Diseases.
    • 05 Mar 2015 According to a Bioiberica media release, results from this study were published in Annals of the Rheumatic Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top